Downregulation of Rab17 promotes cell proliferation and invasion in non‐small cell lung cancer through STAT3/HIF‐1α/VEGF signaling

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2019) D Planchard et al.   ANNALS OF ONCOLOGY

A proteomic approach to identify endosomal cargoes controlling cancer invasiveness

(2017) Jesica Diaz-Vera et al.   JOURNAL OF CELL SCIENCE

Role of miR-497 in VEGF-A-mediated cancer cell growth and invasion in non-small cell lung cancer

(2016) Aiqin Gu et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124/IL-6R/STAT3 axis

(2016) Xingxing Wang et al.   Scientific Reports

Targeted therapies for treatment of non-small cell lung cancer-Recent advances and future perspectives

(2015) Joan Minguet et al.   INTERNATIONAL JOURNAL OF CANCER

Rab17 inhibits the tumourigenic properties of hepatocellular carcinomas via the Erk pathway

(2015) Kejia Wang et al.   TUMOR BIOLOGY

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ

(2014) Jürgen Cox et al.   MOLECULAR & CELLULAR PROTEOMICS

Transcription factor PREP1 induces EMT and metastasis by controlling the TGF- -SMAD3 pathway in non-small cell lung adenocarcinoma

(2014) M. Risolino et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma

(2014) Dongjun Luo et al.   Biomed Research International

Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway

(2013) Zhiqiang Zhao et al.   CANCER LETTERS

ERK2 drives tumour cell migration in three-dimensional microenvironments by suppressing expression of Rab17 and liprin- 2

(2012) A. von Thun et al.   JOURNAL OF CELL SCIENCE

Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?

(2012) Andrew Jarnicki et al.   Cell Division

Epithelial organization, cell polarity and tumorigenesis

(2011) Luke Martin McCaffrey et al.   TRENDS IN CELL BIOLOGY

The epithelial-mesenchymal transition (EMT) phenomenon

(2010) P. Savagner   ANNALS OF ONCOLOGY

Sulforaphane Inhibits Constitutive and Interleukin-6-Induced Activation of Signal Transducer and Activator of Transcription 3 in Prostate Cancer Cells

(2010) E. R. Hahm et al.   Cancer Prevention Research

NF-κB and STAT3 – key players in liver inflammation and cancer

(2010) Guobin He et al.   CELL RESEARCH

Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas

(2010) Ki Taek Nam et al.   JOURNAL OF CLINICAL INVESTIGATION

A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival

(2009) Anurag Singh et al.   CANCER CELL

Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells

(2009) R. Behera et al.   CARCINOGENESIS